Group 1 - The focus is on maintaining a delta neutral portfolio, aiming to be long/short simultaneously to benefit from market volatility [1] - The strategy involves using options for entering and exiting trades, primarily targeting small and mid-sized companies for market opportunities [1]

Intercontinental Exchange Inc. (NYSE:ICE) is one of the best fintech stocks to invest in. On February 5, Intercontinental Exchange announced its earnings for the full year 2025, reporting a 7% year-over-year increase to $9.9 billion. This growth translated into a rise in profitability, with GAAP diluted earnings per share jumping 21% to $5.77 and adjusted diluted EPS rising 14% to $6.95. Q4 revenue totaled $2.50 billion, which was a 7.79% improvement. Performance was strong across all primary business se ...

Coupang (NYSE:CPNG), South Korean e-commerce and technology company, closed Friday at $19.08, up 1.98%. The stock inched higher as investors reacted to stabilization signs following the late‑2025 data incident and are watching how management’s recovery plan and buybacks support earnings quality. Trading volume reached 51.2 million shares, about 125% above its three-month average of 22.7 million shares. Coupang IPO'd in 2021 and has fallen 61% since going public. How the markets moved today S&P 500 slipped ...

With the threat of a ballot initiative looming, a slate of auto dealers in Washington have come out in support of EV makers Rivian and Lucid Motors in their pursuit of direct sales to consumers. Electric automakers have fought for years to change the state law that only allows Tesla to directly sell cars, operate showrooms and offer test drives to potential customers in Washington. The rule exists to prevent manufacturers from competing against franchised dealerships. In December, Rivian began taking steps ...

Anywhere from $40 billion to $150 billion of leveraged loans packaged into US collateralized loan obligations could be disrupted by the artificial intelligence boom, according to JPMorgan Chase & Co. That’s because those loans fall within sectors most associated with AI risk, according to the Wall Street lender, which released its estimate as a recap of the SFVegas 2026 conference where software’s impact on corporate CLOs was “the topic du jour.” Most Read from Bloomberg CLOs offer investors exposure t ...

Core Viewpoint - The article emphasizes the importance of conducting thorough due diligence and research before making any investment decisions, highlighting that past performance does not guarantee future results [2][3]. Group 1 - The author does not hold any stock, options, or similar derivative positions in the companies mentioned and has no plans to initiate such positions in the near future [1]. - The article clarifies that it is not financial advice and that the author is not a licensed financial advisor, urging investors to understand the risks involved in various trading styles [2]. - It is noted that investing in European and non-US stocks may involve specific withholding tax risks, and investors are encouraged to consult tax professionals regarding these matters [2]. Group 2 - The article states that Seeking Alpha does not provide recommendations or advice on the suitability of investments for particular investors, and opinions expressed may not reflect the views of Seeking Alpha as a whole [3]. - The authors of the articles include both professional and individual investors, some of whom may not be licensed or certified by any regulatory body [3].

Core Viewpoint - Sharp Therapeutics Corp. has successfully closed the first tranche of its non-brokered private placement for unsecured convertible notes, raising a total of US$500,000 through the issuance of 500 notes, with proceeds allocated for general working capital purposes [1]. Group 1: Note Offering Details - Each note has a principal amount of US$1,000 and is convertible into common shares at a price of US$2.00 per share, with a conversion option available until 12 months post-closing [2]. - The notes carry an interest rate of 6.0% per annum, calculated as simple interest and payable in cash on the maturity date [3]. - The first tranche included participation from insiders, with STX Partners, LLC acquiring 200 notes for US$200,000, Newlin Investment Company 1, LLC acquiring 100 notes for US$100,000, and others, totaling 350 notes for US$350,000 [4]. Group 2: Regulatory and Compliance Information - The insider participation in the first tranche is classified as a related-party transaction, exempt from formal valuation or minority shareholder approval under Multilateral Instrument 61-101, as the transaction does not exceed 25% of the company's market capitalization [5]. - The company did not file a material change report prior to the closing due to the timing of insider participation details, and no new Control Person will be created as a result of this tranche [6]. Group 3: Future Commitments and Offerings - STX has committed an additional US$800,000 for future contributions in four tranches of US$200,000 each, scheduled for March and April 2026 [7]. - The notes were offered through private placement in Canada and the United States, adhering to applicable exemptions from prospectus requirements [8]. Group 4: Company Overview - Sharp Therapeutics is a preclinical-stage company focused on developing small-molecule therapeutics for genetic diseases, utilizing a discovery platform that combines high throughput screening technologies and computationally optimized compound libraries [10].

Applied Digital (NASDAQ: APLD) has been one of the best stock picks over the past year. It has risen nearly 300% since 2025 began, but it has sharply sold off over the past few weeks. Now, it's down nearly 30% from its all-time high established in January. Applied Digital has been a great stock to own over the past few months, but is now the time to buy? I think it could easily bounce back, especially once the market gets its appetite for artificial intelligence (AI) investing back. Will AI create the worl ...

Paramount Skydance and Warner Bros. Discovery have made it official, and CEO David Ellison sent a memo out to staff about the merger.Paramount said in an official announcement on Friday that it had entered into a definitive merger agreement with Warner Bros. Discovery, giving the David Ellison-run media firm valuable assets such as HBO, CNN, and DC Studios.Netflix, which was also vying for WBD, declined to raise its bid for the company on Thursday.Read the memo Ellison sent:Team,Today we announced that Para ...

Article contentSuch forward-looking statements involve significant risks and uncertainties. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including that the discussions between the parties could be unsuccessful; that the existing agreements could be terminated in accordance with their terms and that Mr. Goldhar does not remain with the Trust; that the terms of any amended, extended, supplemented or replaced definitive agreem ...